Ortu G - Search Results

1

Comparison of the hepatic uptake and processing of cholesterol from chylomicrons of different fatty acid composition in the rat in vivo.

Bravo E, Ortu G, Cantafora A, Lambert MS, Avella M, Mayes PA, Botham KM. Bravo E, et al. Among authors: ortu g. Biochim Biophys Acta. 1995 Oct 5;1258(3):328-36. doi: 10.1016/0005-2760(95)00141-x. Biochim Biophys Acta. 1995. PMID: 7548204

2

The contribution of lipoprotein cholesterol to hepatic precursor pools for bile acid synthesis.

Bravo E, Ortu G, Cantafora A, Guldur T, Mayes PA, Botham KM. Bravo E, et al. Among authors: ortu g. Biochem Soc Trans. 1992 Nov;20(4):338S. doi: 10.1042/bst020338s. Biochem Soc Trans. 1992. PMID: 1487003 No abstract available.

3

Probucol reduces hepatic cholesterol secretion in hyperlipidemic Yoshida rats.

Bravo E, Ortu G, Rivabene R, Santini MT, Cantafora A. Bravo E, et al. Among authors: ortu g. Atherosclerosis. 1996 Jan 26;119(2):223-33. doi: 10.1016/0021-9150(95)05651-3. Atherosclerosis. 1996. PMID: 8808499

4

Ortu G, Rivabene R, Cantafora A, Bravo E. Ortu G, et al. Proc Soc Exp Biol Med. 1997 Oct;216(1):44-51. doi: 10.3181/00379727-216-44154. Proc Soc Exp Biol Med. 1997. PMID: 9316609

5

The effect of cyclic AMP on the biliary secretion of taurocholic acid in the perfused rat liver.

Bravo E, Ortu G, Cantafora A, Botham KM. Bravo E, et al. Among authors: ortu g. Biochem Soc Trans. 1995 Nov;23(4):575S. doi: 10.1042/bst023575s. Biochem Soc Trans. 1995. PMID: 8654760 No abstract available.

6

Evaluation of [O-methyl-(11)C]fluvoxamine as a tracer for serotonin re-uptake sites.

Wollmer P, Moresco RM, Simonelli P, Matarrese M, Rigamonti M, Ortu G, LaGaetana R, Soloviev D, Galli M, Fazio F. Wollmer P, et al. Among authors: ortu g. Nucl Med Biol. 2000 Feb;27(2):177-81. doi: 10.1016/s0969-8051(99)00106-7. Nucl Med Biol. 2000. PMID: 10773547

7

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

Bonasera TA, Ortu G, Rozen Y, Krais R, Freedman NM, Chisin R, Gazit A, Levitzki A, Mishani E. Bonasera TA, et al. Among authors: ortu g. Nucl Med Biol. 2001 May;28(4):359-74. doi: 10.1016/s0969-8051(01)00200-1. Nucl Med Biol. 2001. PMID: 11395308

8

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

Ortu G, Ben-David I, Rozen Y, Freedman NM, Chisin R, Levitzki A, Mishani E. Ortu G, et al. Int J Cancer. 2002 Oct 1;101(4):360-70. doi: 10.1002/ijc.10619. Int J Cancer. 2002. PMID: 12209961

9

Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride.

Ben-David I, Rozen Y, Ortu G, Mishani E. Ben-David I, et al. Among authors: ortu g. Appl Radiat Isot. 2003 Feb;58(2):209-17. doi: 10.1016/s0969-8043(02)00301-9. Appl Radiat Isot. 2003. PMID: 12573320

10

The synthesis of [26,27-11C]dihydroxyvitamin D(3), a tracer for positron emission tomography (PET).

Bonasera TA, Grue-Sørensen G, Ortu G, Binderup E, Bergström M, Björkling F, Långström B. Bonasera TA, et al. Among authors: ortu g. Bioorg Med Chem. 2001 Dec;9(12):3123-8. doi: 10.1016/s0968-0896(01)00178-x. Bioorg Med Chem. 2001. PMID: 11711287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters